The latest update for our Prime Time portfolio is a provider of high-performance glass for LCD televisions, computer monitors, and other information display applications, notes Charles Mizrahi, editor of Hidden Values Alert.
We like the diversification behind Corning (GLW). The company gets 36% of its revenues from Display technologies, 27% from Telecommunications, 12% from Environmental Technology, 17% from Specialty Materials (tablets/mobiles phones), and 8% from Life Sciences.
This diversification reduces the company's exposure to a specific industry, smoothing out potential bumps in the road to a particular segment.
GLW spent more than $700 million on R&D in the past 12 months (about 9% of revenue). The company continues to find applications for its glass technology.
The company can employ its proprietary technology in growth drivers such as the smartwatch and smart television markets, as well as windshields or marker boards.
GLW has more than $10.6 billion of cash and investments on its balance sheet. The company has very little short-term debt ($23 million).
Hot Airline Stocks To Buy Right Now: Service Corporation International (SVC)
Service International Corp., formerly Service Corporation International, incorporated in July 1962, is a provider of deathcare products and services, with a network of funeral service locations and cemeteries primarily operating in the United States and Canada. Its operations consist of funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and related businesses. The Company operates in two segments: funeral and cemetery operations. At December 31, 2011, it operated 1,423 funeral service locations and 374 cemeteries (including 214 funeral service/cemetery combination locations) in North America, which are geographically diversified across 43 states, eight Canadian provinces, and the District of Columbia. Its funeral service and cemetery operations consist of funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and related businesses. The Company sells cemetery property and funeral and cemetery products and services at the time of need and on a preneed basis. In December 2013, the Company announced that it completed its acquisition of Stewart Enterprises, Inc. In May 2014, Carriage Services, Inc. acquired six businesses in New Orleans and Alexandria, Virginia from Service Corporation International.
The Company�� funeral service and cemetery operations consist of funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and related businesses. The Company provides all professional services relating to funerals and cremations, including the use of funeral facilities and motor vehicles and preparation and embalming services. Funeral-related merchandise, including caskets, casket memorialization products, burial vaults, cremation receptacles, cremation memorial products, flowers, and other ancillary products and services, is sold at funeral service locations. Its cemeteries provide cemetery property interment rights, including mausoleum spaces, lots, and lawn cr! ypts, and sell cemetery-related merchandise and services, including stone and bronze memorials, markers, merchandise installations, and burial openings and closings. The Company also sells preneed funeral and cemetery products and services whereby a customer contractually agrees to the terms of certain products and services to be delivered and performed in the future.
During the year ended December 31, 2011, its operations in the United States and Canada were organized into 29 major markets, 47 metro markets, and 78 main street markets. At December 31, 2011, it owned approximately 89% of the real estate and buildings used at its facilities, and the remainder of the facilities were leased. At December 31, 2011, its 374 cemeteries contained a total of approximately 26,540 acres, of which approximately 60% was developed.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
From a struggling department store chain delivering better than expected financial results to a popular photo-printing services provider botched a mass mailing, here's a rundown of the week's smartest moves and biggest blunders in the business world. Keurig Green Mountain (GMCR) -- Winner Coca-Cola (KO) is apparently a coffee addict. The world's leading beverage company turned heads earlier this year when it paid $1.25 billion for a 10 percent stake in Keurig Green Mountain. This week it announced that it's bumping its stake to 16 percent, paying a much higher price for the new shares. Keurig Green Mountain is the company behind the country's most popular single-serve coffee maker. In a few months it plans to enter the carbonated beverage market with Keurig Cold. Coca-Cola is on board to provide soft drink flavors for the machine, and now the company has a greater stake in seeing that Keurig Cold is successful. Shutterfly (SFLY) -- Loser "There's nothing more amazing than bringing a new life into the world," begins a promotion that Shutterfly mailed out this week. "As a new parent you're going to find more to love, more to give and more to share -- we're here to help you every step of the way." Shutterfly intended for the mailing to go out to customers who had recently ordered birth announcements, reminding them that matching thank you cards are now in order for the family and friends who provided gifts for the new baby. The problem here is that the marketing email went out to a far wider base of Shutterfly registered users. Twitter and Facebook were alive with folks joking or complaining about the mishap. It was an amusing blunder for most recipients, but it's easy to see how this kind of missive could hit hard to others. Netflix (NFLX) -- Winner We're apparently a nation of Netflix addicts. Online trend watcher Sandvine (SVC) reports that the streaming video service accounted for 34.2 percent of the North America's peak downstream Internet traffic durin
Top 5 Life Sciences Companies To Buy For 2014: Xueda Education Group(XUE)
Xueda Education Group provides tutoring services for primary and secondary school students in the People?s Republic of China with a focus on offering personalized tutoring services. Its services include consultation and assessment, formulation of a customized study plan, personalized tutoring, and delivery of supporting services. The company also provides course offerings that cover various academic subjects taught in primary and secondary schools, such as mathematics, English, physics, Chinese, and chemistry; and self-designed courses beyond the standard curriculum in certain subjects, as well as in subjects not taught at public primary and secondary schools. As of December 31, 2010, its tutoring service network comprised 207 learning centers and approximately 9,650 full-time service professionals, serving customers located in 53 economically developed cities across 27 of China?s 31 provinces and municipalities. The company was founded in 2001 and is headquartered in Beij ing, the People?s Republic of China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Friday, non-cyclical consumer goods & services shares were relative leaders, up on the day by about 0.09 percent. Among the leading sector stocks, gains came from Rite Aid (NYSE: RAD) and Xueda Education Group (NYSE: XUE). Financial sector was the leading decliner in the US market today.
Top 5 Life Sciences Companies To Buy For 2014: Royale Energy Inc.(ROYL)
Royale Energy, Inc. operates as an independent oil and natural gas producer in the United States. It engages in the production and sale of oil and natural gas; acquisition of oil and gas lease interests and proved reserves; drilling of exploratory and development wells; and sale of working interests in wells to be drilled. The company also owns wells and leases located principally in the Sacramento Basin and San Joaquin Basin in California, as well as in Utah, Texas, and Louisiana. In addition, it holds proved developed producing reserves of oil and natural gas in Texas and Louisiana. As of December 31, 2009, Royale Energy operated 52 natural gas wells in California; owned and operated 7 natural gas wells in Utah; and had non operating interests in 17 oil and gas wells in Texas, 3 in Oklahoma, 1 in California, and 2 in Louisiana. It also had proved developed reserves of 4,563 MMcf and total proved reserves of 4,617 MMcf of natural gas; and proved developed oil reserves of 16 Mbbl and total proved oil reserves of 16 Mbbl. The company was founded in 1986 and is based in San Diego, California.
Advisors' Opinion:- [By James E. Brumley]
Does the name Royale Energy, Inc. (NASDAQ:ROYL) ring a bell? If you're a regular reader of the Small Cap Network site or newsletter, it might. Back on February 3rd, yours truly penned some bullish thoughts on the way ROYL was acting at the time. Given what we had seen up until that time, though Royale Energy had not yet begun to rally, the stock was getting within reach of a monster-sized breakout. Well, that breakout may be underway as of today.
- [By James E. Brumley]
With nothing more than a passing glance at Royale Energy, Inc. (NASDAQ:ROYL), it would be easy to dismiss it as just another volatile small caps... one of many small cap stocks that gets a little squirrelly every now and then. The longer you study the chart of ROYL, however, the clearer it becomes... this chart looks like it's coming out of a slightly bearish lull and working its way into an uptrends.
Top 5 Life Sciences Companies To Buy For 2014: Raptor Pharmaceutical Corp.(RPTP)
Raptor Pharmaceuticals Corp. operates as a biotechnology company in the United States. The company is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. Its clinical stage development products include DR Cysteamine, which is in phase IIb for the treatment of cystinosis; phase IIa for the non-alcoholic steatohepatitis; and phase II for the treatment of Huntington?s disease. Raptor?s clinical-stage products also include Convivia that is in Phase IIa stage for the potential management of acetaldehyde toxicity due to alcohol consumption; and Tezampanel and NGX 426, which completed phase I stage for the treatment of migraine and pain. Its preclinical product candidates comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis; WntTide for the treatment of breast cancer; NeuroTrans for the treatmen t of neurodegenerative diseases; and Tezampanel and NGX 426 for the treatment of Thrombosis and Spasticity Disorder. Raptor Pharmaceuticals Corp. is headquartered in Novato, California.
Advisors' Opinion:- [By Sean Williams]
Veloci-Raptor time?
First up is Raptor Pharmaceuticals (NASDAQ: RPTP ) with Procysbi (previously known as RP-103), its oral delayed and extended-release medication to treat nephropathic cystinosis. In trials, Procysbi proved to be non-inferior to the only other FDA-approved treatment for nephropathic cystinosis, known as Cystagon from Mylan (NASDAQ: MYL ) . - [By Roberto Pedone]
One biotechnology player that's starting to trend within range of triggering a big breakout trade is Raptor Pharmaceuticals (RPTP), which has a pipeline that includes both candidates from its proprietary drug targeting platforms and in-licensed and acquired product candidates. This stock is in play with the bulls so far in 2013, with shares up sharply by 151%.
>>5 Hated Earnings Stocks You Should Love
If you take a look at the chart for Raptor Pharmaceuticals, you'll notice that stock has been uptrending strong for the last six months, with shares soaring higher from its low of $5.50 to its recent high of $15.29 a share. During that uptrend, shares of RPTP have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RPTP within range of triggering a big breakout trade.
Traders should now look for long-biased trades in RPTP if it manages to break out above some near-term overhead resistance levels at $14.99 a share to its 52-week high at $15.29 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 844,332 shares. If that breakout triggers soon, then RPTP will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $18 to $20 a share, or even north of $20 a share.
Traders can look to buy RPTP off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $13.69 a share or at $13 a share. One can also buy RPTP off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Jake L'Ecuyer]
Equities Trading UP
Raptor Pharmaceuticals (NASDAQ: RPTP) shot up 16.62 percent to $17.40 after the company announced positive clinical results with RP103 in Huntington's disease Phase 2/3 trial. - [By Sean Williams]
This week saw two new drugs approved by the FDA: Raptor Pharmaceuticals' (NASDAQ: RPTP ) Procysbi and Merck's (NYSE: MRK ) Liptruzet.
No comments:
Post a Comment